141 related articles for article (PubMed ID: 17602722)
1. Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior.
Chen W; Li F; Mead L; White H; Walker J; Ingram DA; Roman A
Virology; 2007 Oct; 367(1):168-74. PubMed ID: 17602722
[TBL] [Abstract][Full Text] [Related]
2. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
Toussaint-Smith E; Donner DB; Roman A
Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115
[TBL] [Abstract][Full Text] [Related]
3. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
5. Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration.
Walker J; Smiley LC; Ingram D; Roman A
Virology; 2011 Feb; 410(2):283-90. PubMed ID: 21159359
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
7. Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.
Berger KL; Barriga F; Lace MJ; Turek LP; Zamba GJ; Domann FE; Lee JH; Klingelhutz AJ
Virology; 2006 Dec 5-20; 356(1-2):68-78. PubMed ID: 16945398
[TBL] [Abstract][Full Text] [Related]
8. Identification of miRNAs dysregulated in human foreskin keratinocytes (HFKs) expressing the human papillomavirus (HPV) Type 16 E6 and E7 oncoproteins.
Yablonska S; Hoskins EE; Wells SI; Khan SA
Microrna; 2013; 2(1):2-13. PubMed ID: 25070710
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6.
McKenna DJ; McDade SS; Patel D; McCance DJ
J Virol; 2010 Oct; 84(20):10644-52. PubMed ID: 20702634
[TBL] [Abstract][Full Text] [Related]
10. Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes.
Gyöngyösi E; Szalmás A; Ferenczi A; Kónya J; Gergely L; Veress G
Virol J; 2012 Feb; 9():36. PubMed ID: 22333115
[TBL] [Abstract][Full Text] [Related]
11. HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes.
Narisawa-Saito M; Handa K; Yugawa T; Ohno S; Fujita M; Kiyono T
Oncogene; 2007 May; 26(21):2988-96. PubMed ID: 17146442
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
13. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.
Hyland PL; McDade SS; McCloskey R; Dickson GJ; Arthur K; McCance DJ; Patel D
J Virol; 2011 Nov; 85(21):10999-1006. PubMed ID: 21865393
[TBL] [Abstract][Full Text] [Related]
14. High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7.
Aromseree S; Middeldorp JM; Pientong C; van Eijndhoven M; Ramayanti O; Lougheed SM; Pegtel DM; Steenbergen RD; Ekalaksananan T
PLoS One; 2017; 12(1):e0169290. PubMed ID: 28056059
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins.
Gyöngyösi E; Szalmás A; Ferenczi A; Póliska S; Kónya J; Veress G
Arch Virol; 2015 Feb; 160(2):389-98. PubMed ID: 25488293
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
[TBL] [Abstract][Full Text] [Related]
17. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
18. miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes.
McKenna DJ; Patel D; McCance DJ
Virology; 2014 Jan; 448():210-6. PubMed ID: 24314651
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic potential diverge among human papillomavirus type 16 natural variants.
Sichero L; Sobrinho JS; Villa LL
Virology; 2012 Oct; 432(1):127-32. PubMed ID: 22748253
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization.
Vandermark ER; Deluca KA; Gardner CR; Marker DF; Schreiner CN; Strickland DA; Wilton KM; Mondal S; Woodworth CD
Virology; 2012 Mar; 425(1):53-60. PubMed ID: 22284893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
